The head and neck cancer drugs industry continues to witness significant innovation and growth driven by advancements in targeted therapies and immunotherapies. Increasing prevalence of head and neck malignancies and rising adoption of precision medicine are shaping the competitive landscape and fueling business growth across regions. https://hallbook.com.br/blogs/824711/Head-and-Neck-Cancer-Drugs-Market-Growth-Driven-by-Innovative